Silencing of ApoE with Divalent siRNAs Drives Activation of Immune Clearance Pathways and Improves Amyloid Pathology in Mouse Models of Alzheimer's Disease
Ferguson, C.; Hildebrand, S.; Godinho, B. M. D. C.; Buchwald, J.; Echeverria, D.; Coles, A.; Grigorenko, A.; Vanjielli, L.; Sousa, J.; McHugh, N.; Hassler, M.; Santarelli, F.; Heneka, M. T.; Rogaev, E.; Khvorova, A.
Show abstract
The most common genetic risk factor for late-onset Alzheimers disease (AD) is the APOE4 allele, with evidence for gain- and loss-of-function mechanisms. ApoE knockout in mice abrogates AD phenotypes but causes severe atherosclerosis due to the role of liver ApoE in cholesterol homeostasis. Previous attempts to inhibit brain-specific ApoE with anti-sense oligonucleotides only modestly reduced ApoE expression and had no effect on amyloid burden in adult AD mice. Here, we optimized a divalent small interfering RNA (di-siRNA) to selectively and potently silence ApoE in the brain. Silencing brain ApoE in AD mice significantly reduced amyloid plaque formation without affecting systemic cholesterol levels, confirming that brain and liver APOE pools are spatially and functionally distinct. Mechanistically, APOE appears to be a scaffold for beta-amyloid aggregation that limits clearance by microglia. Di-siRNAs from this study can be taken to pre-clinical and clinical trials to accelerate development of AD-modifying therapies and establish siRNA-based modulation of ApoE as a viable path towards therapeutic development.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Microglia initially seed and later reshape amyloid plaques in Alzheimer's disease 97%
- Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy 96%
- Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy 96%
Similar papers in this journal
- The Alzheimers Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states 95%
- Microglial Piezo1 senses Aβ fibrils stiffness to restrict Alzheimer's disease 95%
- A systems biology-based identification and in vivo functional screening of Alzheimer's disease risk genes reveals modulators of memory function 95%
Similar papers in this journal
- Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model 95%
- Cystatin F (Cst7) drives sex-dependent changes in microglia in an amyloid-driven model of Alzheimer's Disease 95%
- A microglia clonal inflammatory disorder in Alzheimer's Disease 95%
Similar papers in this journal
- Sustained TREM2 stabilization accelerates microglia heterogeneity and Abeta pathology in a mouse model of Alzheimer s disease 97%
- Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer's disease 96%
- Applying high-resolution spatial transcriptomics to characterise the amyloid plaque cell niche in Alzheimer's Disease 95%
Similar papers in this journal
- TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration 96%
- Molecular characterization of selectively vulnerable neurons in Alzheimer's Disease 96%
- Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in an Alzheimer's disease model 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.